Dr. James C. Yao on Everolimus in Pancreatic Neuroendocrine Tumors
13 Mga view
• 07/13/23
0
0
I-embed
administrator
Mga subscriber
James C. Yao, MD, discusses the administration of everolimus (Afinitor) for patients with pancreatic neuroendocrine tumors
For more resources and information regarding targeted therapies in cancer: http://targetedhc.com/
Magpakita ng higit pa
Mga Komento sa Facebook
SORT BY-
Mga Nangungunang Komento
-
Pinakabagong komento